Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

flesinoxan

Known as: p-fluoro-N-(2-(4-(2-(hydroxymethyl)-1,4-benzodioxan-5-yl)-1-piperazinyl)ethyl)benzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
  • J. Monti
  • Sleep medicine reviews
  • 2011
  • Corpus ID: 29773003
Based on electrophysiological, neurochemical, genetic and neuropharmacological approaches, it is currently accepted that… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2008
Review
2008
Based on electrophysiological, neurochemical and neuropharmacological approaches, it is currently accepted that serotonin (5-HT… Expand
  • figure 1
  • table 1
  • table 2
Highly Cited
2001
Highly Cited
2001
The present study investigated the acute effects of flesinoxan (a selective 5-HT(1A) receptor agonist), fluvoxamine (a selective… Expand
Highly Cited
1998
Highly Cited
1998
The effects of treatment with anxiogenic or anxiolytic agents and exposure to acute restraint stress on emotional behavior in… Expand
Highly Cited
1998
Highly Cited
1998
This study examined the influence of the highly selective 5‐HT1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the… Expand
Highly Cited
1998
Highly Cited
1998
The aminomethylchroman derivative BAY x 3702 (R-(-)-2-[4-[(chroman-2-ylmethyl)-amino]-butyl]-1,1-dioxo-benzo[d] isothiazolone… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 6
Highly Cited
1995
Highly Cited
1995
The effects of the selective 5-HT1A receptor agonist flesinoxan on neuroendocrine function, temperature, and behavior were… Expand
Highly Cited
1995
Highly Cited
1995
Flesinoxan is a high affinity and selective 5-hydroxytryptamine1A (5-HT1A) ligand which, unlike the 5-HT1A agonists of the… Expand
Highly Cited
1993
Highly Cited
1993
Flesinoxan, a full 5-HT1A, receptor agonist, was administered (4–8 mg) to treatment-resistant depressed patients in an open study… Expand
Highly Cited
1988
Highly Cited
1988
Flesinoxan, a new phenylpiperazine derivative has been shown to lower blood pressure in different species after both oral and i.v… Expand